SEC Tracker
Get the app

Femasys FEMY

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue ® Diagnostic Device

Form
8-K
Filed
Importance
Routine
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Femasys files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. DarioHealth DRIO public float $28M, Jun 30, 2025
  2. Cerenome CNSY public float $32M, Jun 30, 2025
  3. electroCore ECOR public float $28M, Jun 30, 2025
  4. QT Imaging Holdings QTI public float $33M, Jun 30, 2025
  5. Nephros NEPH public float $27M, Jun 30, 2025